In our review, two studies reported conflicting results regarding the efficacy of topical GM-CSF for OM (Sprinzl et al., 2001; Hejna et al., 2001), although this discrepancy might have been related to the use of RT. This evidence concerns the gene CSF2 and ocular melanoma.